Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.

MLA

Wally, Verena, et al. “Small Molecule Drug Development for Rare Genodermatoses - Evaluation of the Current Status in Epidermolysis Bullosa.” Orphanet Journal of Rare Diseases, vol. 15, no. 1, Oct. 2020, p. 292. EBSCOhost, https://doi.org/10.1186/s13023-020-01467-9.

APA

Wally, V., Reisenberger, M., Kitzmüller, S., & Laimer, M. (2020). Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa. Orphanet Journal of Rare Diseases, 15(1), 292. https://doi.org/10.1186/s13023-020-01467-9

Chicago

Wally, Verena, Manuela Reisenberger, Sophie Kitzmüller, and Martin Laimer. 2020. “Small Molecule Drug Development for Rare Genodermatoses - Evaluation of the Current Status in Epidermolysis Bullosa.” Orphanet Journal of Rare Diseases 15 (1): 292. doi:10.1186/s13023-020-01467-9.